Levitra
Product Images NDC 67544-507

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levitra (NDC 67544-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil HCl (levitra) 20mg Tablets (67544 507)

Packaging label for Vardenafil HCl (Levitra) 20 mg, containing 2 tablets. The label includes storage instructions, manufacturer Bayer Corporation (West Haven, CT), and repackager Aphena Pharma (Cookeville, TN). It also indicates prescription status (Rx Only) and displays barcodes and NDC 67544-0507-02.*

FDA Label Image

Vardenafil HCl (levitra) 10mg Tablets (67544 512)

Label for Levitra containing Vardenafil HCl 10 mg tablets, with a package count of 6 tablets. The label includes storage instructions, manufacturer Bayer Corporation in West Haven, CT, and repackager Aphena Pharma in Cookeville, TN. It also notes 'RX Only' and displays multiple barcodes and the NDC number 67544-0512-06.*

FDA Label Image

Structural Formula (Bfc7a65d 372d 4748 8bb9 C5467a87207c 01)

Chemical structure diagram of the active ingredient in Levitra, showing molecular components and a notation indicating it is a hydrochloride trihydrate salt.*

FDA Label Image

Figure 1 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 02)

A pharmacokinetic line graph showing plasma concentration (µg/L) of Levitra over a 24-hour period. The x-axis represents time in hours, and the y-axis shows plasma concentration levels. Data points include error bars indicating variability at each time interval.*

FDA Label Image

Figure 2 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 03)

Three line graphs showing the mean material change over time in systolic blood pressure, diastolic blood pressure, and heart rate (bpm) relative to the timing of Vardenafil treatment compared to Pre-NTG. The x-axis represents time points at 24h, 8h, 4h, and 1h before treatment, with mean changes trending downward for blood pressures and fluctuating for heart rate.*

FDA Label Image

Figure 3 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 04)

This line graph compares the mean change in mmHg over a 6-hour period following administration of a placebo or Vardenafil at doses of 5 mg and 6 mg. Data are presented for both simultaneous and 6-hour separation dosing conditions, showing variation in blood pressure change over time for each group.*

FDA Label Image

Figure 4 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 05)

A line graph depicting mean change in mmHg over time (hours) comparing placebo and Vardenafil 5 mg under simultaneous and 8-hour separation conditions. The x-axis represents time in hours, and the y-axis shows mean change in mmHg. Different lines indicate the varying treatment conditions.*

FDA Label Image

Figure 5 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 06)

A line graph showing mean change in mmHg (millimeters of mercury) over time in hours. The graph compares four groups: Placebo Stage 1, Placebo Stage 2, Vardenafil 10 mg, and Vardenafil 20 mg. Each group is represented by different markers and lines, illustrating fluctuations in mean change over a 6-hour period.*

FDA Label Image

Figure 6 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 07)

A line graph titled 'TERAZOSIN' showing mean change in blood pressure (mmHg) over 6 hours. The x-axis represents time (hours) from 0 to 6, and the y-axis represents mean change in blood pressure (mmHg). Multiple lines compare placebo, 10 mg and 20 mg of Vardenafil under conditions of blood pressure lowering through 8 hr separation and simultaneous administration.*

FDA Label Image

Figure 7 (Bfc7a65d 372d 4748 8bb9 C5467a87207c 08)

A line graph titled 'TAMSULOSIN' showing mean change in blood pressure (mmHg) on the vertical axis over time in hours on the horizontal axis. Multiple data series represent different treatments: placebo with either separate or simultaneous administration, and 10 mg or 20 mg Vardenafil with either separate or simultaneous administration. The graph displays trends for mean blood pressure changes over a 6-hour period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.